Dean B. Reardon

1.7k total citations
23 papers, 1.4k citations indexed

About

Dean B. Reardon is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Dean B. Reardon has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 3 papers in Genetics. Recurrent topics in Dean B. Reardon's work include Melanoma and MAPK Pathways (6 papers), Cancer-related Molecular Pathways (6 papers) and Protein Tyrosine Phosphatases (4 papers). Dean B. Reardon is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Cancer-related Molecular Pathways (6 papers) and Protein Tyrosine Phosphatases (4 papers). Dean B. Reardon collaborates with scholars based in United States, Germany and Australia. Dean B. Reardon's co-authors include Paul Dent, Rupert Schmidt‐Ullrich, Kristoffer Valerie, Geoffrey Bowers, Ross B. Mikkelsen, Thomas W. Sturgill, Joseph N. Contessa, Jong Sung Park, Craig D. Logsdon and Cyrus Amir and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Dean B. Reardon

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dean B. Reardon United States	18	791	595	315	232	184	23	1.4k
Cataldo Bianco Italy	24	757 1.0×	765 1.3×	427 1.4×	252 1.1×	169 0.9×	37	1.5k
David R. Emlet United States	16	1.3k 1.7×	598 1.0×	216 0.7×	231 1.0×	155 0.8×	24	2.1k
Paul J. Adam Austria	15	952 1.2×	442 0.7×	145 0.5×	210 0.9×	167 0.9×	23	1.5k
Hany Kayed Germany	23	923 1.2×	640 1.1×	138 0.4×	263 1.1×	90 0.5×	45	1.5k
Ruoqian Shen United States	18	593 0.7×	442 0.7×	551 1.7×	283 1.2×	111 0.6×	27	1.2k
Roberto E. Favoni Italy	20	844 1.1×	541 0.9×	356 1.1×	327 1.4×	41 0.2×	39	1.6k
Rohan Bareja United States	15	824 1.0×	362 0.6×	517 1.6×	390 1.7×	118 0.6×	42	1.4k
Mikinori Sato Japan	19	603 0.8×	704 1.2×	164 0.5×	302 1.3×	52 0.3×	59	1.4k
Iván Plaza-Menacho United Kingdom	20	598 0.8×	490 0.8×	241 0.8×	197 0.8×	44 0.2×	27	1.3k
Vasyl Vasko United States	21	659 0.8×	602 1.0×	169 0.5×	293 1.3×	97 0.5×	38	1.7k

Countries citing papers authored by Dean B. Reardon

Since Specialization

Citations

This map shows the geographic impact of Dean B. Reardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean B. Reardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean B. Reardon more than expected).

Fields of papers citing papers by Dean B. Reardon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean B. Reardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean B. Reardon. The network helps show where Dean B. Reardon may publish in the future.

Co-authorship network of co-authors of Dean B. Reardon

This figure shows the co-authorship network connecting the top 25 collaborators of Dean B. Reardon. A scholar is included among the top collaborators of Dean B. Reardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean B. Reardon. Dean B. Reardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bent, Martin J. van den, Lisa Roberts-Rapp, Peter Ansell, et al.. (2015). 2903 Identifying the correct patient (pt) population for ABT-414: Biomarker assays for epidermal growth factor receptor (EGFR) in pts with glioblastoma (GBM). European Journal of Cancer. 51. S585–S586. 2 indexed citations

Frentzas, Sophia, Morris D. Groves, Jorge Barriuso, et al.. (2009). Pazopanib and lapatinib in patients with relapsed malignant glioma: Results of a phase I/II study. Journal of Clinical Oncology. 27(15_suppl). 2040–2040. 9 indexed citations

Reardon, Dean B., Timothy F. Cloughesy, C. Conrad, et al.. (2005). A phase I study of AEE788, a novel multitargeted inhibitor of ErbB and VEGF receptor family tyrosine kinases, in recurrent GBM patients. Journal of Clinical Oncology. 23(16_suppl). 3063–3063. 22 indexed citations

Sabbisetti, Venkata, Shibu Thomas, Kedar S. Vaidya, et al.. (2005). Calcitonin increases invasiveness of prostate cancer cells: Role for cyclic AMP-dependent protein kinase A in calcitonin action. International Journal of Cancer. 117(4). 551–560. 35 indexed citations

Lammering, Guido, William Hawkins, Joseph N. Contessa, et al.. (2001). Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell Radiosensitization. JNCI Journal of the National Cancer Institute. 93(12). 921–929. 78 indexed citations

Bowers, Geoffrey, Dean B. Reardon, Paul Dent, et al.. (2001). The relative role of ErbB1–4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene. 20(11). 1388–1397. 132 indexed citations

Dent, Paul, Craig D. Logsdon, Barbara Nicke, et al.. (2001). Recombinant adenoviral expression of dominant-negative ras N17 blocking radiation-induced activation of mitogen-activated protein kinase pathway. Methods in enzymology on CD-ROM/Methods in enzymology. 333. 28–37. 2 indexed citations

Sundaram, Sujatha, M. Ahmad Chaudhry, Dean B. Reardon, Mridula Gupta, & David A. Gewirtz. (2000). The vitamin D3 analog EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells. Breast Cancer Research and Treatment. 63(1). 1–10. 56 indexed citations

Schmidt‐Ullrich, Rupert, Joseph N. Contessa, Paul Dent, et al.. (1999). Molecular mechanisms of radiation-induced accelerated repopulation. Radiation Oncology Investigations. 7(6). 321–330. 85 indexed citations

10.

Park, Jong Sung, Stephen Carter, Dean B. Reardon, et al.. (1999). Roles for Basal and Stimulated p21^{Cip-1/WAF1/MDA6}Expression and Mitogen-activated Protein Kinase Signaling in Radiation-induced Cell Cycle Checkpoint Control in Carcinoma Cells. Molecular Biology of the Cell. 10(12). 4231–4246. 43 indexed citations

11.

Reardon, Dean B., Joseph N. Contessa, Ross B. Mikkelsen, et al.. (1999). Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene. 18(33). 4756–4766. 108 indexed citations

12.

Contessa, Joseph N., Dean B. Reardon, Daniel G. Todd, et al.. (1999). The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells.. PubMed. 5(2). 405–11. 66 indexed citations

13.

Dent, Paul, Dean B. Reardon, Jong Sung Park, et al.. (1999). Radiation-induced Release of Transforming Growth Factor α Activates the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway in Carcinoma Cells, Leading to Increased Proliferation and Protection from Radiation-induced Cell Death. Molecular Biology of the Cell. 10(8). 2493–2506. 279 indexed citations

14.

Auer, Kelly L., Dean B. Reardon, Michael J. Birrer, et al.. (1998). Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene. 16(21). 2787–2796. 133 indexed citations

15.

Reardon, Dean B., Paul Dent, Steven L. Wood, Ting Kong, & Thomas W. Sturgill. (1997). ActivationIn Vitroof Somatostatin Receptor Subtypes 2, 3, or 4 Stimulates Protein Tyrosine Phosphatase Activity in Membranes from Transfected Ras-Transformed NIH 3T3 Cells: Coexpression with Catalytically Inactive SHP-2 Blocks Responsiveness. Molecular Endocrinology. 11(8). 1062–1069. 70 indexed citations

16.

Dent, Paul, Yining Wang, Steven L. Wood, et al.. (1997). S49 Cells Endogenously Express Subtype 2 Somatostatin Receptors Which Couple to Increase Protein Tyrosine Phosphatase Activity in Membranes and Down-regulate Raf-1 Activity In Situ. Cellular Signalling. 9(7). 539–549. 18 indexed citations

17.

Dent, Paul, Dean B. Reardon, Steven L. Wood, et al.. (1996). Inactivation of Raf-1 by a Protein-tyrosine Phosphatase Stimulated by GTP and Reconstituted by Gαi/o Subunits. Journal of Biological Chemistry. 271(6). 3119–3123. 33 indexed citations

18.

Reardon, Dean B., Steven L. Wood, David L. Brautigan, et al.. (1996). Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin. Biochemical Journal. 314(2). 401–404. 38 indexed citations

19.

Dent, Paul, Dean B. Reardon, Deborah K. Morrison, & Thomas W. Sturgill. (1995). Regulation of Raf-1 and Raf-1 Mutants by Ras-Dependent and Ras-Independent Mechanisms In Vitro. Molecular and Cellular Biology. 15(8). 4125–4135. 120 indexed citations

20.

Reardon, Dean B. & Mien‐Chie Hung. (1993). Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.. Journal of Biological Chemistry. 268(24). 18136–18142. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact